George D. Yancopoulos
2012
In 2012, George D. Yancopoulos earned a total compensation of $81.6M as President, Regeneron Laboratories and Chief Scientific Officer at Regeneron Pharmaceuticals, a 713% increase compared to previous year.
Compensation breakdown
| Bonus | $1,955,000 |
|---|---|
| Option Awards | $21,442,383 |
| Salary | $850,000 |
| Stock Awards | $57,275,000 |
| Other | $29,065 |
| Total | $81,551,448 |
Yancopoulos received $57.3M in stock awards, accounting for 70% of the total pay in 2012.
Yancopoulos also received $2M in bonus, $21.4M in option awards, $850K in salary and $29.1K in other compensation.
Rankings
In 2012, George D. Yancopoulos' compensation ranked 3rd out of 11,487 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3 out of 11,487 | 100th |
Division Manufacturing | 2 out of 4,252 | 100th |
Major group Chemicals And Allied Products | 1 out of 1,200 | 100th |
Industry group Drugs | 1 out of 922 | 100th |
Industry Pharmaceutical Preparations | 1 out of 697 | 100th |
Source: SEC filing on April 21, 2015.
Yancopoulos' colleagues
We found four more compensation records of executives who worked with George D. Yancopoulos at Regeneron Pharmaceuticals in 2012.
2012
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2012
Neil Stahl
Regeneron Pharmaceuticals
Executive Vice President, Research & Development
2012
Murray Goldberg
Regeneron Pharmaceuticals
Chief Financial Officer
2012
Robert Terifay
Regeneron Pharmaceuticals
Senior Vice President, Commercial
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019